References
1. Agency for Healthcare Research and Quality. Management of
Bronchiolitis in Infants and Children. Evidence Report/ Technology
Assessment No. 69. Rockville, MD: Agency for Healthcare Research and
Quality; 2003. AHRQ Publication No. 03- E014
2.
Pierangeli
A, Scagnolari C, Antonelli G: Respiratory syncytial virus.
Minerva
Pediatr. 2018 Dec;70(6):553-565.
3
Fitzgerald
DA, Kilham HA. Bronchiolitis: assessment and evidence-based management.
Med J Aust 2004; 180:399.
4
Stein
RT, Bont LJ, Zar H, et al. Respiratory syncytial virus hospitalization
and mortality: Systematic review and meta-analysis. Pediatr Pulmonol
2017; 52:556.
5
Shi
T, McAllister DA, O’Brien KL, et al. Global, regional, and national
disease burden estimates of acute lower respiratory infections due to
respiratory syncytial virus in young children in 2015: a systematic
review and modelling study. Lancet 2017; 390:946.
6 Flores-Gonzalez JC, Mayordomo-Colunga J, Jordan I et al (2017)
Prospective multicenter study on the epidemiology and current
therapeutic management of severe bronchiolitis in Spain. Biomed Res Int
2017:2565397
7
Boyce
TG, Mellen BG, Mitchel EF Jr, et al. Rates of hospitalization for
respiratory syncytial virus infection among children in medicaid. J
Pediatr 2000; 137:865.
8
Munywoki
PK, Koech DC, Agoti CN, et al. Frequent Asymptomatic Respiratory
Syncytial Virus Infections During an Epidemic in a Rural Kenyan
Household Cohort. J Infect Dis 2015; 212:1711.
9
Sheridan-Pereira
M, Murphy J, Sloan J, et al. Respiratory Syncytial Virus Preterm (32-36
Completed Weeks of Gestation) Risk Estimation Measure for RSV
Hospitalization in Ireland: A Prospective Study. Pediatr Infect Dis J
2016; 35:19.
10
Welliver
RC Sr, Checchia PA, Bauman JH, et al. Fatality rates in published
reports of RSV hospitalizations among high-risk and otherwise healthy
children. Curr Med Res Opin 2010; 26:2175.
11
Mitchell
I, Wong SK, Paes B, et al. Respiratory syncytial virus prophylaxis in
cystic fibrosis: the Canadian registry of palivizumab data (2005-2016).
Eur J Clin Microbiol Infect Dis 2018; 37:1345.
12
Kristensen
K, Stensballe LG, Bjerre J, et al. Risk factors for respiratory
syncytial virus hospitalisation in children with heart disease. Arch Dis
Child 2009; 94:785.
13
Gijtenbeek
RG, Kerstjens JM, Reijneveld SA, et al. RSV infection among children
born moderately preterm in a community-based cohort. Eur J Pediatr 2015;
174:435.
14
von
Linstow ML, Høgh M, Nordbø SA, et al. A community study of clinical
traits and risk factors for human metapneumovirus and respiratory
syncytial virus infection during the first year of life. Eur J Pediatr
2008; 167:1125.
15
Maedel
C, Kainz K, Frischer T, et al. Increased severity of respiratory
syncytial virus airway infection due to passive smoke exposure. Pediatr
Pulmonol 2018; 53:1299.
16. Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE,
Gadomski AM, et al. Clinical practice guideline: the diagnosis,
management, and prevention of bronchiolitis. Pediatrics
2014;134:e1474-e1502
17 Wood DW, Downes JJ, Lecks HI. A clinical scoring system for the
diagnosis of respiratory failure. Preliminary report on childhood status
asthmaticus. Am J Dis Child 1972;123:227-228
18 Arcavi L, Benowitz NL: Cigarette smoking and infection. Arch Intern
Med. 2004;164(20):2206.
19 Zar HJ, Ferkol TW. The global burden of respiratory disease—impact
on child health. Pediatr Pulmonol. 2014;49:430–434
20
Behrooz
L, Balekian DS, Faridi MK, et al: Prenatal and postnatal
tobacco smoke exposure and risk of severe bronchiolitis during infancy.
Respir Med. 2018
Jul;140:21-26.
21 Lanari M, Vandini S, Adorni F, et al. Prenatal tobacco smoke exposure
increases hospitalizations for bronchiolitis in infants. Respir Res.
2015;16:1–9
22 Stevenson MD, Mansbach JM, Mowad E, et al. Prenatal versus postnatal
tobacco smoke exposure and intensive care use in children hospitalized
with bronchiolitis. Acad Pediatr. 2016;16:446–452. Epub 2015/11/12.
23
Ghazaly
M, Nadel S. Characteristics of children admitted to intensive care with
acute bronchiolitis.
Eur J Pediatr. 2018
Jun;177(6):913-920
24
Pham
H, Thompson
J, Wurzel
D, Duke
T. Ten years of severe respiratory syncytial virus infections in a
tertiary paediatric intensive care unit. J Paediatr Child Health. 2020
Jan;56(1):61-67
25 Matt GE, Wahlgren DR, Hovell MF, et al. Measuring environmental
tobacco smoke exposure in infants and young children through urine
cotinine and memory-based parental reports: empirical findings and
discussion. Tob Control. 1999;8(3):282-289. doi:10.1136/tc.8.3.282
26 Miller EK, Gebretsadik T, Carroll KN, et al: Viral etiologies of
infant bronchiolitis, croup and upper respiratory illness during 4
consecutive years. Pediatr Infect Dis J. 2013;32(9):950–955
27
Wiegers
HM,
Nijen
L, Van
Woensel JBM, et al. Bacterial co-infection of the respiratory tract in
ventilated children with bronchiolitis; a retrospective cohort study.
BMC Infect
Dis. 2019;19:938.
28 Thorburn K, Harigopal S, Reddy V, et al. High incidence of pulmonary
bacterial co-infection in children with severe respiratory syncytial
virus (RSV) bronchiolitis. Thorax. 2006;61:611–615. doi:
10.1136/thx.2005.048397
29 Duttweiler L, Nadal D, Frey B. Pulmonary and systemic bacteria
co-infections in severe RSV bronchiolitis. Arch Dis
Child. 2004;89:1155–1157. doi: 10.1136/adc.2004.049551
30 Randolph AG, Reder L, Englund JA: Risk of bacterial infection in
previously healthy respiratory syncytial virus-infected young children
admitted to the intensive care unit. Pediatr Infect Dis J. 2004;23:
990-994.